Lutgarde Lynen

6.6k total citations · 1 hit paper
177 papers, 4.2k citations indexed

About

Lutgarde Lynen is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lutgarde Lynen has authored 177 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Infectious Diseases, 86 papers in Epidemiology and 28 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lutgarde Lynen's work include HIV/AIDS Research and Interventions (53 papers), Tuberculosis Research and Epidemiology (49 papers) and Pneumocystis jirovecii pneumonia detection and treatment (28 papers). Lutgarde Lynen is often cited by papers focused on HIV/AIDS Research and Interventions (53 papers), Tuberculosis Research and Epidemiology (49 papers) and Pneumocystis jirovecii pneumonia detection and treatment (28 papers). Lutgarde Lynen collaborates with scholars based in Belgium, United States and South Africa. Lutgarde Lynen's co-authors include Johan van Griensven, Robert Colebunders, Marleen Boelaert, Graeme Meintjes, Sopheak Thai, Ermias Diro, Robert J. Wilkinson, Rogelio López‐Vélez, Asrat Hailu and Charles F. Gilks and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Lutgarde Lynen

167 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

2008 519 citations Graeme Meintjes, Gary Maartens et al. profile →

Peers

Countries citing papers authored by Lutgarde Lynen

Since Specialization

Citations

This map shows the geographic impact of Lutgarde Lynen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutgarde Lynen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutgarde Lynen more than expected).

Fields of papers citing papers by Lutgarde Lynen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lutgarde Lynen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutgarde Lynen. The network helps show where Lutgarde Lynen may publish in the future.

Co-authorship network of co-authors of Lutgarde Lynen

This figure shows the co-authorship network connecting the top 25 collaborators of Lutgarde Lynen. A scholar is included among the top collaborators of Lutgarde Lynen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lutgarde Lynen. Lutgarde Lynen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ThiPhiSA: new pathways to TB prevention from community screening – a household-randomised controlled trial in KwaZulu-Natal, South Africa 2025 ·BMJ Open ·(unknown), (unknown), Katherine K. Thomas, Cole Grabow, (unknown), Jennifer F. Morton, Klaus Reither, Lutgarde Lynen, Alastair van Heerden, Zaynab Essack, (unknown), Adrienne E. Shapiro	0
2	Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB 2024 ·SHILAP Revista de lepidopterología ·(unknown), Ruth Laryea, (unknown), (unknown), Natalie Lorent, Dorcas Obiri‐Yeboah, Lutgarde Lynen, Leen Rigouts	2
3	Low tuberculosis treatment initiation after positive tuberculosis lipoarabinomannan results 2024 ·ERJ Open Research ·(unknown), (unknown), (unknown), Irene Ayakaka, Alastair van Heerden, Erika Vlieghe, Moniek Bresser, Tom Decroo, Lutgarde Lynen, Klaus Reither, (unknown)	1
4	Realist evaluation of a community-based antiretroviral therapy (CBART) programme for key populations in Benue State in Nigeria 2024 ·BMC Infectious Diseases ·(unknown), Tom Decroo, Caroline Masquillier, Prosper Okonkwo, Lutgarde Lynen, (unknown), Josefien van Olmen, Sara Van Belle	0
5	Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa 2024 ·Clinical Infectious Diseases ·(unknown), Irene Ayakaka, (unknown), (unknown), Alastair van Heerden, (unknown), Niklaus Daniel Labhardt, Gregor Sommer, Jens Bremerich, Thomas Zöller, Keelin Murphy, Bram van Ginneken, Alfred Keter, Bart K. M. Jacobs, Moniek Bresser, Aita Signorell, Tracy R. Glass, Lutgarde Lynen, Klaus Reither	2
6	Attrition one year after starting antiretroviral therapy before and after the programmatic implementation of HIV “Treat All” in Sub-Saharan Africa: a systematic review and meta-analysis 2023 ·BMC Infectious Diseases ·Richard Makurumidze, Tom Decroo, Bart K. M. Jacobs, Simbarashe Rusakaniko, Wim Van Damme, Lutgarde Lynen, (unknown)	3
7	Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidity 2023 ·International Health ·(unknown), Tom Decroo, Éric Florence, Koert Ritmeijer, Josefien van Olmen, Lutgarde Lynen	0
8	High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin 2023 ·International Journal of Infectious Diseases ·Mahamadou Bassirou Souleymane, (unknown), Alberto Piubello, Achilleas Tsoumanis, (unknown), (unknown), (unknown), Armand Van Deun, Lutgarde Lynen, Bouke C. de Jong, Tom Decroo	8
9	Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study 2022 ·International Health ·Mahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, (unknown), (unknown), (unknown), Eric Adéhossi, Nimer Ortuño‐Gutiérrez, Lutgarde Lynen, Leen Rigouts, Bouke C. de Jong, Armand Van Deun, Alberto Piubello	2
10	Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol 2022 ·BMJ Open ·(unknown), Lutgarde Lynen, Josephine Muhairwe, (unknown), Thabo Ishmael Lejone, Philip Joseph, Thulani Ngubane, Alfred Keter, Klaus Reither, Alastair van Heerden	4
11	Comparison of first-line tuberculosis treatment outcomes between previously treated and new patients: a retrospective study in Machakos subcounty, Kenya 2020 ·International Health ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lutgarde Lynen, Tom Decroo	8
12	The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance 2020 ·PLoS ONE ·Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, M. Anwar Hossain, Mourad Gumusboga, Wim Mulders, Nimer Ortuño‐Gutiérrez, Lutgarde Lynen, Bouke C. de Jong, Hans L. Rieder	13
13	Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia 2020 ·BMC Infectious Diseases ·Jozefien Buyze, Anja De Weggheleire, Johan van Griensven, Lutgarde Lynen	3
14	Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study 2019 ·Global Health Action ·(unknown), Tom Decroo, (unknown), Natalie Lorent, (unknown), Jacob Creswell, Andrew James Codlin, Lutgarde Lynen, Sopheak Thai	5
15	Temporary disengagement and re-engagement in human immunodeficiency virus care in a rural county serving pastoralist communities in Kenya: a retrospective cohort study 2019 ·International Health ·(unknown), (unknown), Lutgarde Lynen, Tom Decroo	4
16	Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study 2019 ·International Health ·(unknown), (unknown), Lutgarde Lynen, Tom Decroo	9
17	Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes 2017 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Sopheak Thai, Lutgarde Lynen, Johan van Griensven	4
18	Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial) 2016 ·JMIR Research Protocols ·Cari Stek, Charlotte Schutz, (unknown), Friedrich Thienemann, Jozefien Buyze, Christiana Nöstlinger, Raffaella Ravinetto, Edwin Wouters, Robert Colebunders, Gary Maartens, Robert J. Wilkinson, Lutgarde Lynen, Graeme Meintjes	10
19	Genotypic Impact of Prolonged Detectable HIV Type 1 RNA Viral Load after HAART Failure in a CRF01_AE-Infected Cohort 2010 ·AIDS Research and Human Retroviruses ·María Zolfo, Jonathan Schapiro, (unknown), Olivier Koole, Sopheak Thai, Marc Vekemans, Katrien Fransen, Lutgarde Lynen	14
20	Clinical algorithm for malaria in Africa [letter] 1996 ·The Lancet ·J Van den Ende, (unknown), Lutgarde Lynen, Wim Van Damme	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact